Opportunistic strains of Saccharomyces cerevisiae: A potential risk sold in food products

Frontiers in Microbiology

Volumn 6, Issue JAN, 2016, Pages

  Pérez Torrado, Roberto ^a   Querol, Amparo ^a  

^a INSTITUTO DE AGROQUÍMICA Y TECNOLOGÍA DE ALIMENTOS CSIC   (Spain)

Author keywords

Food; Infection; Opportunistic; S. cerevisiae; Yeast

Indexed keywords

BEER; DIET SUPPLEMENTATION; HUMAN; HUMAN VERSUS NONHUMAN DATA; PATHOGENESIS; SACCHAROMYCES CEREVISIAE; SCIENTIST; SPECIES;

EID: 84957990105     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.01522     Document Type: Short Survey

References (53)

1. Bodey, G., Bueltmann, B., Duguid, W., Gibbs, D., Hanak, H., Hotchi, M., et al. (1992). Fungal infections in cancer patients: an international autopsy survey. Eur. J. Clin. Microbiol. Infect. Dis. 11, 99-109. doi: 10.1007/BF01967060.
2. Bogdan, C., Rollinghoff, M., and Diefenbach, A. (2000). Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr. Opin. Immunol. 12, 64-76. doi: 10.1016/S0952-7915(99)00052-7.
3. Brown, A. J., Budge, S., Kaloriti, D., Tillmann, A., Jacobsen, M. D., Yin, Z., et al. (2014). Stress adaptation in a pathogenic fungus. J. Exp. Biol. 217, 144-155. doi: 10.1242/jeb.088930.
4. Brown, A. J., Haynes, K., and Quinn, J. (2009). Nitrosative and oxidative stress responses in fungal pathogenicity. Curr. Opin. Microbiol. 12, 384-391. doi: 10.1016/j.mib.2009.06.007.
5. Brown, S. M., Campbell, L. T., and Lodge, J. K. (2007). Cryptococcus neoformans, a fungus under stress. Curr. Opin. Microbiol. 10, 320-325. doi: 10.1016/j.mib.2007.05.014.
6. Carreto, L., Eiriz, M. F., Gomes, A. C., Pereira, P. M., Schuller, D., and Santos, M. A. (2008). Comparative genomics of wild type yeast strains unveils important genome diversity. BMC Genomics 9:524. doi: 10.1186/1471-2164-9-524.
7. Dalle, F., Wachtler, B., L'Ollivier, C., Holland, G., Bannert, N., Wilson, D., et al. (2010). Cellular interactions of Candida albicans with human oral epithelial cells and enterocytes. Cel. Microbiol. 12, 248-271. doi: 10.1111/j.1462-5822.2009.01394.x.
8. de Llanos, R., Fernandez-Espinar, M. T., and Querol, A. (2006). A comparison of clinical and food Saccharomyces cerevisiae isolates on the basis of potential virulence factors. Antonie Van Leeuwenhoek 90, 221-231. doi: 10.1007/s10482-006-9077-7.
9. de Llanos, R., Llopis, S., Molero, G., Querol, A., Gi, C., and Fernandez-Espinar, M. T. (2011). In vivo virulence of commercial Saccharomyces cerevisiae strains with pathogenicity-associated phenotypical traits. Int. J. Food. Microbiol. 144, 393-399. doi: 10.1016/j.ijfoodmicro.2010.10.025.
10. de Llanos, R., Querol, A., Planes, A. M., and Fernández-Espinar, M. T. (2004). Molecular characterization of clinical Saccharomyces cerevisiae isolates and their association with non-clinical strains. Syst. Appl. Microbiol. 27, 427-435. doi: 10.1078/0723202041438473.
11. Diezmann, S., and Dietrich, F. S. (2011). Oxidative stress survival in a clinical Saccharomyces cerevisiae isolate is influenced by a major quantitative trait nucleotide. Genetics 188, 709-722. doi: 10.1534/genetics.111.128256.
12. Donovan, M., Schumuke, J. J., Fonzi, W. A., Bonar, S. L., Gheesling-Mullis, K., Jacob, G. S., et al. (2001). Virulence of a phosphoribosyl aminoimidazole carboxylase-deficient Candida albicans strain in an immunosuppressed murine model of systemic candidiasis. Infect. Immun. 69, 2542-2548. doi: 10.1128/IAI.69.4.2542-2548.2001.
13. Enache-Angoulvant, A., and Hennequin, C. (2005). Invasive Saccharomyces infection: a comprehensive review. Clin. Infect. Dis. 41, 1559-1568. doi: 10.1086/497832.
14. Fradin, C., De Groot, P., MacCallum, D., Schaller, M., Klis, F., Odds, F. C., et al. (2005). Granulocytes govern the transcriptional response, morphology and proliferation of Candida albicans in human blood. Mol. Microbiol. 56, 397-415. doi: 10.1111/j.1365-2958.2005.04557.x.
15. Fradin, C., Kretschmar, M., Nichterlein, T., Gaillardin, C., d'Enfert, C., and Hube, B. (2003). Stage-specific gene expression of Candida albicans in human blood. Mol. Microbiol. 47, 1523-1543. doi: 10.1046/j.1365-2958.2003.03396.x.
16. Herbrecht, R., and Nivoix, Y. (2005). Saccharomyces cerevisiae fungemia: an adverse effect of Saccharomyces boulardii probiotic administration. Clin. Infect. Dis. 40, 1635-1637. doi: 10.1086/429926.
17. Idnurm, A., and Howlett, B. J. (2002). Isocitrate lyase is essential for pathogenicity of the fungus Leptosphaeria maculans to canola (Brassica napus). Eukaryot. Cell 1, 719-724. doi: 10.1128/EC.1.5.719-724.2002.
18. Jensen, D. P., and Smith, D. L. (1976). Fever of unknown origin secondary to brewer's yeast ingestion. Arch. Intern. Med. 136, 332-333. doi: 10.1001/archinte.1976.03630030064011.
19. Jiang, L., Zhao, J., Guo, R., Li, J., Yu, L., and Xu, D. (2010). Functional characterization and virulence study of ADE8 and GUA1 genes involved in the de novo purine biosynthesis in Candida albicans. FEMS Yeast Res. 10, 199-208. doi: 10.1111/j.1567-1364.2009.00600.x.
20. Kingsbury, J. M., Goldstein, A. L., and McCusker, J. H. (2006). Role of nitrogen and carbon transport, regulation, and metabolism genes for Saccharomyces cerevisiae survival in vivo. Eukaryot. Cell 5, 816-824. doi: 10.1128/EC.5.5.816-824.2006.
21. Kirdis, E., Jonsson, I. M., Kubica, M., Potempa, J., Josefsson, E., and Masalha, M. (2007). Ribonucleotide reductase class III, an essential enzyme for the anaerobic growth of Staphylococcus aureus, is a virulence determinant in septic arthritis. Microb. Pathog. 3, 179-188. doi: 10.1016/j.micpath.2007.05.008.
22. Le Breton, Y., Mistry, P., Valdes, K. M., Quigley, J., Kumar, N., Tettelin, H., et al. (2013). Genome-wide identification of genes required for fitness of group a Streptococcus in human blood. Infect. Immun. 81, 862-875. doi: 10.1128/IAI.00837-12.
23. Lin, L., Ibrahim, A. S., Baquir, B., Palosaari, A., and Spellberg, B. (2012). Luminescent-activated transfected killer cells to monitor leukocyte trafficking during systemic bacterial and fungal infection. J. Infect. Dis. 205, 337-347. doi: 10.1093/infdis/jir72522124127.
24. Liti, G., Carter, D. M., Moses, A. M., Warringer, J., Parts, L., James, S. A., et al. (2009). Population genomics of domestic and wild yeasts. Nature 458, 337-341. doi: 10.1038/nature07743.
25. Llopis, S., Hernández-Haro, C., Monteoliva, L., Querol, A., Molina, M., and Fernández-Espinar, M. T. (2014). Pathogenic potential of Saccharomyces strains isolated from dietary supplements. PLoS ONE 9:e98094. doi: 10.1371/journal.pone.0098094.
26. Llopis, S., Querol, A., Heyken, A., Hube, B., Jespersen, L., Fernandez-Espinar, T., et al. (2012). Transcriptomics in human blood incubation reveals the importance of oxidative stress response in Saccharomyces cerevisiae clinical strains. BMC Genomics 13:419. doi: 10.1186/1471-2164-13-419.
27. Lorenz, M. C., Bender, J. A., and Fink, G. R. (2004). Transcriptional response of Candida albicans upon internalization by macrophages. Eukaryot. Cell 3, 1076-1087. doi: 10.1128/EC.3.5.1076-1087.2004.
28. Lorenz, M. C., and Fink, G. R. (2001). The glyoxylate cycle is required for fungal virulence. Nature 412, 83-86. doi: 10.1038/35083594.
29. Lushchak, O. V., Inoue, Y., and Lushchak, V. I. (2010). Regulatory protein Yap1 is involved in response of yeast Saccharomyces cerevisiae to nitrosative stress. Biochemistry (Mosc.) 75, 629-664. doi: 10.1134/S0006297910050135.
30. Martin, G. S., Mannino, D. M., Eaton, S., and Moss, M. (2003). The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348, 1546-1554. doi: 10.1056/NEJMoa022139.
31. McCullough, M. J., Clemons, K. V., McCusker, J. H., and Stevens, D. A. (1998). Species identification and virulence attributes of Saccharomyces boulardii (nom. inval.). J. Clin. Microbiol. 36, 2613-2617.
32. McCusker, J. H., Clemons, K. V., Stevens, D. A., and Davis, R. W. (1994). Saccharomyces cerevisiae virulence phenotype as determined with CD-1 mice is associated with the ability to grow at 42 degrees C and form pseudohyphae. Infect. Immun. 62, 5447-5455.
33. McKinney, J. D., Honerzu, B. K., Munoz-Elias, E. J., Miczak, A., Chen, B., Chan, W. T., et al. (2000). Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 406, 735-738. doi: 10.1038/35021074.
34. Missall, T. A., and Lodge, J. K. (2005). Function of the thioredoxin proteins in Cryptococcus neoformans during stress or virulence and regulation by putative transcriptional modulators. Mol. Microbiol. 57, 847-858. doi: 10.1111/j.1365-2958.2005.04735.x.
35. Morrow, C. A., Valkov, E., Stamp, A., Chow, E. W., Lee, I. R., Wronski, A., et al. (2012). De novo GTP biosynthesis is critical for virulence of the fungal pathogen Cryptococcus neoformans. PLoS Pathog. 8:e1002957. doi: 10.1371/journal.ppat.1002957.
36. Muñoz, P., Bouza, E., Cuenca-Estrella, M., Eiros, J. M., Perez, M. J., Sanchez-Somolinos, M., et al. (2005). Saccharomyces cerevisiae fungemia: an emerging infectious disease. Clin. Infect. Dis. 40, 1625-1634. doi: 10.1086/429916.
37. Panosa, A., Roca, I., and Gibert, I. (2010). Ribonucleotide reductases of Salmonella typhimurium transcriptional regulation and differential role in pathogenesis. PLoS ONE 5:e11328. doi: 10.1371/journal.pone.0011328.
38. Pérez-Torrado, R., Llopis, S., Jespersen, L., Fernández-Espinar, T., and Querol, A. (2012). Clinical Saccharomyces cerevisiae isolates cannot cross the epithelial barrier in vitro. Int. J. Food Microbiol. 157, 59-64. doi: 10.1016/j.ijfoodmicro.2012.04.012.
39. Pérez-Torrado, R., Llopis, S., Perrone, B., Gómez-Pastor, R., Hube, B., and Querol, A. (2015). Comparative genomic analysis reveals a critical role of de novo nucleotide biosynthesis for Saccharomyces cerevisiae virulence. PLoS ONE 10:e0122382. doi: 10.1371/journal.pone.0122382.
40. Pfaller, M. A., and Diekema, D. J. (2007). Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev. 20, 133-163. doi: 10.1128/CMR.00029-06.
41. Puig-Asensio, M., Padilla, B., Garnacho-Montero, J., Zaragoza, O., Aguado, J. M., Zaragoza, R., et al. (2014). Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain. Clin. Microbiol. Infect. 20, O245-O254. doi: 10.1111/1469-0691.12380.
42. Rodrigues-Pousada, C., Menezes, R. A., and Pimentel, C. (2010). The Yap family and its role in stress response. Yeast 27, 245-258. doi: 10.1002/yea.1752.
43. Rodriguez-Suarez, R., Xu, D., Veillette, K., Davison, J., Sillaots, S., Kauffman, S., et al. (2007). Mechanism-of-action determination of GMP synthase inhibitors and target validation in Candida albicans and Aspergillus fumigatus. Chem. Biol. 14, 1163-1175. doi: 10.1016/j.chembiol.2007.09.009.
44. Rubin-Bejerano, I., Fraser, I., Grisafi, P., and Fink, G. R. (2003). Phagocytosis by neutrophils induces an amino acid deprivation response in Saccharomyces cerevisiae and Candida albicans. Proc. Natl. Acad. Sci. U.S.A. 100, 11007-11012. doi: 10.1073/pnas.1834481100.
45. Rude, T. H., Toffaletti, D. L., Cox, G. M., and Perfect, J. R. (2002). Relationship of the glyoxylate pathway to the pathogenesis of Cryptococcus neoformans. Infect. Immun. 70, 5684-5694. doi: 10.1128/IAI.70.10.5684-5694.2002.
46. Samant, S., Lee, H., Ghassemi, M., Chen, J., Cook, J. L., Mankin, A. S., et al. (2008). Nucleotide biosynthesis is critical for growth of bacteria in human blood. PLoS Pathog. 4:e37. doi: 10.1371/journal.ppat.0040037.
47. Sjöberg, B. M., and Torrents, E. (2011). Shift in ribonucleotide reductase gene expression in Pseudomonas aeruginosa during infection. Infect. Immun. 79, 2663-2669. doi: 10.1128/IAI.01212-10.
48. Smalley, D., Rocha, E. R., and Smith, C. J. (2002). Aerobic-type ribonucleotide reductase in the anaerobe Bacteroides fragilis. J. Bacteriol. 184, 895-903. doi: 10.1128/jb.184.4.895-903.2002.
49. Smith, D., Metzgar, D., Wills, C., and Fierer, J. (2002). Fatal Saccharomyces cerevisiae aortic graft infection. J. Clin. Microbiol. 40, 2691-2692. doi: 10.1128/JCM.40.7.2691-2692.2002.
50. Strope, P. K., Skelly, D. A., Kozmin, S. G., Mahadevan, G., Stone, E. A., Magwene, P. M., et al. (2015). The 100-genomes strains, an S. cerevisiae resource that illuminates its natural phenotypic and genotypic variation and emergence as an opportunistic pathogen. Genome Res. 25, 762-774. doi: 10.1101/gr.185538.114.
51. Wei, W., McCusker, J. H., Hyman, R. W., Jones, T., Ning, Y., Cao, Z., et al. (2007). Genome sequencing and comparative analysis of Saccharomyces cerevisiae strain YJM789. Proc. Natl. Acad. Sci. U.S.A. 104, 12825-12830. doi: 10.1073/pnas.0701291104.
52. Wright, W. L., and Wenzel, R. P. (1997). Nosocomial candida epidemiology, transmission, and prevention. Infect. Dis. Clin. North. Am. 11, 411-425. doi: 10.1016/S0891-5520(05)70363-9.
53. Zakikhany, K., Naglik, J. R., Schmidt-Westhausen, A., Holland, G., Schaller, M., and Hube, B. (2007). In vivo transcript profiling of Candida albicans identifies a gene essential for interepithelial dissemination. Cell. Microbiol. 9, 2938-2954. doi: 10.1111/j.1462-5822.2007.01009.x.